(1)
Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-World Settings: PROAK Study Protocol. J of Skin 2022, 6 (2), s19. https://doi.org/10.25251/skin.6.supp.19.